Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

UroGen Pharma (URGN) Shares Issued (2017 - 2025)

Historic Shares Issued for UroGen Pharma (URGN) over the last 9 years, with Q3 2025 value amounting to $7.6 million.

  • UroGen Pharma's Shares Issued fell 4905.69% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 9472.78%. This contributed to the annual value of $151.2 million for FY2024, which is 12442.62% up from last year.
  • According to the latest figures from Q3 2025, UroGen Pharma's Shares Issued is $7.6 million, which was down 4905.69% from $297000.0 recorded in Q2 2025.
  • In the past 5 years, UroGen Pharma's Shares Issued registered a high of $80.1 million during Q2 2024, and its lowest value of $3000.0 during Q3 2021.
  • Over the past 5 years, UroGen Pharma's median Shares Issued value was $378000.0 (recorded in 2022), while the average stood at $15.2 million.
  • As far as peak fluctuations go, UroGen Pharma's Shares Issued surged by 5589020.98% in 2024, and later tumbled by 9994.65% in 2025.
  • UroGen Pharma's Shares Issued (Quarter) stood at $3000.0 in 2021, then soared by 12500.0% to $378000.0 in 2022, then skyrocketed by 17504.23% to $66.5 million in 2023, then plummeted by 77.45% to $15.0 million in 2024, then plummeted by 49.06% to $7.6 million in 2025.
  • Its Shares Issued was $7.6 million in Q3 2025, compared to $297000.0 in Q2 2025 and $30000.0 in Q1 2025.